Have a personal or library account? Click to login
Surgical Outcomes Following Fluorescence Cholangiography-Guided Laparoscopic Cholecystectomy in Patients with Moderate Acute Cholecystitis Cover

Surgical Outcomes Following Fluorescence Cholangiography-Guided Laparoscopic Cholecystectomy in Patients with Moderate Acute Cholecystitis

Open Access
|Jan 2026

Abstract

In patients with moderate acute cholecystitis, there is an increased risk of iatrogenic bile duct injury during laparoscopic cholecystectomy. Fluorescence cholangiography (FC) can improve visualisation of extra hepatic bile ducts intra-operatively and can assist in achieving critical view of safety (CVS) principles. The present prospective observational study focuses on the efficacy of FC with indocyanine green (ICG) in patients with moderate acute cholecystitis who underwent laparoscopic cholecystectomy at our department between October 2021 and April 2024. We compared visualisation rates of extrahepatic bile ducts, both before and after achieving CVS along with FC-ICG. We were also interested in the post-operative surgical outcomes. Descriptive statistics were used to present our results. In our cohort of 33 patients (52% female) with moderate acute cholecystitis, the acute gangrenous subtype (56.2%) was the most common followed by the acute phlegmonous form (43.8%). The median operative time was 85 minutes with three patients requiring conversion to an open approach. When comparing before and after CVS achievement, FC-ICG improved the visualisation of extrahepatic biliary tree structures including the cystic duct (52% vs 70%), common bile duct (48% vs 70%), and common hepatic duct (33% vs 46%). Median hospitalisation duration was six days with no patient reporting any post-operative complications. Consequently, the median post-operative patient well-being score was 80%. FC-ICG improves the visualisation of extrahepatic biliary tree structures during laparoscopic cholecystectomy in patients with acute moderate cholecystitis, thereby increasing success rates and reducing complication rates.

DOI: https://doi.org/10.2478/prolas-2025-0019 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 253 - 260
Submitted on: Oct 7, 2025
|
Accepted on: Nov 19, 2025
|
Published on: Jan 18, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2026 Jānis Pāvulāns, Tatjana Ivanova, Fatjona Smakiqi, Jānis Opincāns, Elza Sondore, Krista Brigita Čerpakovska, Kaspars Zeiza, Haralds Plaudis, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution 4.0 License.